Manufacturer Supply, High Purity, Commercial Production
| Chemical Name |
7-(4-Chlorobutoxy)quinolin-2(1H)-one |
| Synonyms |
7-(4-Chlorobutoxy)-1H-Quinolin-2-one; Brexpiprazole Impurity 23 |
| CAS Number |
913613-82-8 |
| CAT Number |
RF-PI1980 |
| Stock Status |
In Stock, Production Scale Up to Tons |
| Molecular Formula |
C13H14ClNO2 |
| Molecular Weight |
251.71 |
| Boiling Point |
460.8±45.0℃ |
| Density |
1.216±0.06 g/cm3 |
| Brand |
Ruifu Chemical |
| Item |
Specifications |
| Appearance |
Pale Yellow to Pale Beige Solid |
| Purity / Analysis Method |
>98.0% (HPLC) |
| Infrared Spectrum |
Conforms to Structure |
| NMR |
Conforms to Structure |
| Test Standard |
Enterprise Standard |
| Usage |
Intermediate / Impurity of Brexpiprazole (CAS: 913611-97-9) |
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement
Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture
7-(4-Chlorobutoxy)quinolin-2(1H)-one (CAS: 913613-82-8) is an intermediate / impurity of Brexpiprazole (CAS: 913611-97-9). Brexpiprazole is an atypical antipsychotic drug. It is a D2 dopamine partial agonist called serotonin-dopamine activity modulator (SDAM). The drug received FDA approval on July 13, 2015 for the treatment of schizophrenia, and as an adjunctive treatment for depression. Although Brexpiprazole failed Phase II clinical trials for ADHD, Brexpiprazole has been designed to provide improved efficacy and tolerability (e.g., less akathisia, restlessness and/or insomnia) over established adjunctive treatments for major depressive disorder (MDD).